EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:757275 - spartalizumab
| ChEBI ID | CHEBI:757275 |
| ChEBI Name | spartalizumab |
| Stars | |
| Last Modified | 30 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| spartalizumab (CHEBI:757275) has role antineoplastic agent (CHEBI:35610) |
| spartalizumab (CHEBI:757275) is a organic molecular entity (CHEBI:50860) |
| INNs | Source |
|---|---|
| espartalizumab | WHO MedNet |
| spartalizumab | WHO MedNet |
| Synonyms | Source |
|---|---|
| ANTI-PD1 MONOCLONAL ANTIBODY PDR001 | ChEMBL |
| NVP-LZV184 | ChEMBL |
| PDR-001 | ChEMBL |
| PDR001 | ChEMBL |